| Literature DB >> 35838531 |
Vishnu M Chandra1, Luke R Wilkins1, David L Brautigan1.
Abstract
Animal models play a crucial role in developing and testing new therapies for hepatocellular carcinoma (HCC), providing preclinical evidence prior to exploring human safety and efficacy outcomes. The interventional radiologist must weigh the advantages and disadvantages of various animal models available when testing a new local-regional therapy. This review highlights the currently available animal models for testing local-regional therapies for HCC and details the importance of considering animal genetics, tumor biology, and molecular mechanisms when ultimately choosing an animal model. Keywords: Animal Studies, Interventional-Vascular, Molecular Imaging-Clinical Translation, Molecular Imaging-Cancer, Chemoembolization, Liver © RSNA, 2022.Entities:
Keywords: Animal Studies; Chemoembolization; Interventional-Vascular; Liver; Molecular Imaging-Cancer; Molecular Imaging-Clinical Translation
Mesh:
Year: 2022 PMID: 35838531 PMCID: PMC9358488 DOI: 10.1148/rycan.210098
Source DB: PubMed Journal: Radiol Imaging Cancer ISSN: 2638-616X